You are on Trendlyne United States. Click here to go to India website or make United States as your default
  1. MARKETS
  2. SECTOR : HEALTHCARE EQUIPMENT & SUPPLIES
  3. INDUSTRY : MEDICAL SPECIALTIES
  4. PULSE BIOSCIENCES INC

Pulse Biosciences Inc XNAS: PLSE

Pulse Biosciences Inc Live Share Price Today, Share Analysis and Chart

Download real time

17.29 -0.45 (-2.54%)

30.84% Fall from 52W High

127.1K XNAS Volume

XNAS 21 Apr, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
Durability score
Not Eligible
-
Valuation Score
Expensive Valuation
1.5 / 100
Momentum Score
Technically Neutral
43.0 / 100
Analyst Price Target
No estimates available

15

S

5

W

1

O

2

T

SWOT Analysis

Check P/E Buy Sell Zone

This stock has negative PE


Pulse Biosciences Inc Live Price Chart

Switch to TradingView
Fetching data ...

Pulse Biosciences Inc Stock Analysis

Pulse Biosciences Inc stock analysis with key metrics, changes, and trends.

Pulse Biosciences Inc MetricVALUECHANGE %TRENDANALYSIS
Annual Net Profit$53.58 M26.95%negative

Annual Net Profit fell 26.95% in the last year to $53.58 M. Its sector's average net profit growth for the last fiscal year was 4.36%.

Price to Earning Ratio-21.71-negative

Price to Earning Ratio is -21.71, which is negative.

Stock Price$17.29140.47%positive

Stock Price rose 140.47% and outperformed its sector by 134.95% in the past year.

Quarterly Net profit$19.38 M62.45%negative

Quarterly Net profit fell 62.45% YoY to $19.38 M. Its sector's average net profit growth YoY for the quarter was 32.9%.

Mutual Fund Holding6.84 %-0.37%negative

Mutual Fund Holding decreased by 0.37% in the last quarter to 6.84.

Promoter Share Holding233.41 %0.29%positive

Promoter Share Holding increased by 0.29% in the most recent quarter to 233.41%.

Institutional Holding8.99 %0.01%positive

Institutional Holding increased by 0.01% in the last quarter to 8.99.

VIEW LESS


Loading data..

Pulse Biosciences Inc - Company Profile

What does Pulse Biosciences Inc do?

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.

Pulse Biosciences Inc Management structure

All Gross Remunerations are in USD
Mr. Darrin R. Uecker
Chief Technology Officer and Director
-
2025
Gross Remuneration
Year
Mr. Paul A. Laviolette
Co-Chairman of the Board, Chief Executive Officer and President
-
2025
Gross Remuneration
Year
Mr. Kevin P. Danahy
Chief Commercial Officer
-
2025
Gross Remuneration
Year
Mr. Jon Skinner
Chief Financial Officer
-
2025
Gross Remuneration
Year

Pulse Biosciences Inc Board of directors

All Gross Remunerations are in USD
Mr. Darrin R. Uecker
Chief Technology Officer and Director
-
2025
Gross Remuneration
Year
Mr. Paul A. Laviolette
Co-Chairman of the Board, Chief Executive Officer
-
2025
Gross Remuneration
Year

Pulse Biosciences Inc FAQ

How is Pulse Biosciences Inc today?
Pulse Biosciences Inc today is trading in the red, and is down by -2.54% at 17.29.
Pulse Biosciences Inc is currently trading down -2.54% on an intraday basis. In the past week the stock rose 7.79%. stock has been down -1.82% in the past quarter and rose 140.47% in the past year. You can view this in the overview section.